Danaher (DHR) vs Freenome (FRNM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Freenome (FRNM) has outperformed Danaher (DHR) over the past year, gaining 51.2% versus a gain of 4.7%. Danaher is the larger company by market cap ($149.58 billion vs $1.71 billion), about 87.6 times the size. Danaher pays a dividend yielding 0.68%, while Freenome does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DHR | FRNM |
|---|---|---|
| Share price | $212.78 | $15.90 |
| Market cap | $149.58B | $1.71B |
| 1-day change | -2.61% | -0.81% |
| YTD return | -4.56% | +23.02% |
| 1-year return | +4.66% | +51.23% |
| 5-year return | -18.22% | — |
| P/E ratio (TTM) | 37.93 | — |
| Forward P/E | 22.88 | — |
| EPS (TTM) | $5.61 | $-2.04 |
| Dividend yield | 0.68% | 0.00% |
| Annual dividend | $1.44 | $0.00 |
| Revenue (latest FY) | $24.57B | — |
| Revenue growth (YoY) | +2.90% | — |
| Net income (latest FY) | $3.61B | — |
| Gross margin | 59.11% | — |
| Operating margin | 19.09% | — |
| Net margin | 14.71% | — |
| 52-week high | $242.80 | $17.50 |
| 52-week low | $160.93 | $9.95 |
| Distance from 52-week high | -12.36% | -9.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +12.35% | +13.21% |
| Average volume | 4.70M | 789.56K |
| Shares outstanding | 702.99M | 107.45M |
| Employees | 58,000 | 375 |
| Sector | Industrials | Health Care |
| Industry | Industrial Machinery/Components | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Danaher is about 87.6 times larger than Freenome by market value ($149.58B vs $1.71B).
- FRNM has outperformed DHR by 46.6 percentage points over the past year.
- The two companies sit in different sectors: Danaher in Industrials and Freenome in Health Care.
About Danaher
DHR stock →Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Industrials · Industrial Machinery/Components · 58,000 employees
About Freenome
FRNM stock →Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.
Health Care · Medical Specialities · 375 employees
DHR vs FRNM FAQ
Which is bigger, Danaher or Freenome?
Danaher (DHR) is larger, with a market capitalization of $149.58B compared with $1.71B for Freenome (FRNM).
Which stock has performed better over the past year, DHR or FRNM?
FRNM returned +51.23% over the past 12 months, compared with +4.66% for DHR (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Danaher or Freenome?
Danaher pays a dividend yielding 0.68%, while Freenome does not currently pay a regular dividend.
Are Danaher and Freenome in the same industry?
No. Danaher is in the Industrials sector, while Freenome is in Health Care.